Michael Klichinsky

Michael Klichinsky

Company: Carisma Therapeutics

Job title: Co-Founder & VP, Discovery


Mike is a co-inventor of the CAR Macrophage technology and a scientific co-founder of Carisma Therapeutics Inc. In his role as VP of Discovery Research, he oversees the research & discovery efforts of the company. 

Mike developed CAR Macrophages during his doctoral thesis under the co-mentorship of Saar Gill and Carl June at the University of Pennsylvania. Michael’s scientific expertise is in the intersection of immunology, synthetic biology, cancer immunotherapy, and translational pharmacology. 

Mike previously earned a Doctor of Pharmacy degree from the University of Sciences in Philadelphia, and a PhD in Pharmacology from the University of Pennsylvania. 


Live Q&A with Your Expert Speakers 1:35 pm

Use this opportunity to ask your expert speakers those burning questions!Read more

day: Day One

Engineered CAR Macrophages & Monocytes – Hijacking the Solid Tumor Microenvironment 12:45 pm

Outline challenges that the solid tumor microenvironment imposes onto adoptive cellular therapies Discuss Carisma’s first-in-class myeloid cell therapies: CAR macrophages and CAR monocytes Discuss CT-0508 (Anti-HER2 CAR-M): Pre-clinical data, impact on the solid TME, and interaction with the endogenous immune systemRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.